Natixis Advisors
MYGN icon

Natixis Advisors’s Myriad Genetics MYGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-212,138
Closed -$1.88M 1668
2025
Q1
$1.88M Buy
212,138
+2,810
+1% +$24.9K ﹤0.01% 1104
2024
Q4
$2.87M Sell
209,328
-110,685
-35% -$1.52M 0.01% 995
2024
Q3
$8.77M Buy
320,013
+44,646
+16% +$1.22M 0.02% 691
2024
Q2
$6.74M Buy
275,367
+37,002
+16% +$905K 0.01% 720
2024
Q1
$5.08M Buy
238,365
+48,087
+25% +$1.03M 0.01% 789
2023
Q4
$3.64M Buy
190,278
+58,449
+44% +$1.12M 0.01% 846
2023
Q3
$2.12M Sell
131,829
-6,695
-5% -$107K 0.01% 968
2023
Q2
$3.21M Buy
138,524
+29,645
+27% +$687K 0.01% 841
2023
Q1
$2.53M Buy
108,879
+50,773
+87% +$1.18M 0.01% 882
2022
Q4
$843K Buy
58,106
+5,538
+11% +$80.3K ﹤0.01% 1187
2022
Q3
$1M Buy
52,568
+34,873
+197% +$665K ﹤0.01% 1109
2022
Q2
$322K Buy
17,695
+2,938
+20% +$53.5K ﹤0.01% 1361
2022
Q1
$372K Buy
+14,757
New +$372K ﹤0.01% 1337
2017
Q3
Sell
-109,275
Closed -$2.82M 1044
2017
Q2
$2.82M Buy
109,275
+14,375
+15% +$371K 0.03% 614
2017
Q1
$1.82M Buy
94,900
+6,202
+7% +$119K 0.02% 725
2016
Q4
$1.48M Sell
88,698
-2,145
-2% -$35.8K 0.02% 746
2016
Q3
$1.87M Buy
90,843
+6,272
+7% +$129K 0.02% 665
2016
Q2
$2.59M Buy
84,571
+19,779
+31% +$605K 0.04% 566
2016
Q1
$2.43M Buy
64,792
+38,658
+148% +$1.45M 0.04% 569
2015
Q4
$1.13M Buy
26,134
+7,966
+44% +$344K 0.02% 748
2015
Q3
$681K Buy
18,168
+2,002
+12% +$75K 0.01% 848
2015
Q2
$549K Buy
16,166
+217
+1% +$7.37K 0.01% 891
2015
Q1
$565K Buy
15,949
+1,743
+12% +$61.7K 0.01% 893
2014
Q4
$484K Buy
14,206
+180
+1% +$6.13K 0.01% 927
2014
Q3
$541K Buy
14,026
+1,506
+12% +$58.1K 0.01% 894
2014
Q2
$487K Sell
12,520
-2,686
-18% -$104K 0.01% 1005
2014
Q1
$520K Sell
15,206
-43,738
-74% -$1.5M 0.01% 937
2013
Q4
$1.24M Buy
58,944
+10,606
+22% +$223K 0.02% 680
2013
Q3
$1.14M Buy
48,338
+4,910
+11% +$115K 0.02% 654
2013
Q2
$1.17M Buy
+43,428
New +$1.17M 0.02% 644